BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11397087)

  • 1. Yet another numbering scheme for immunoglobulin variable domains: an automatic modeling and analysis tool.
    Honegger A; Plückthun A
    J Mol Biol; 2001 Jun; 309(3):657-70. PubMed ID: 11397087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains.
    Abhinandan KR; Martin AC
    Mol Immunol; 2008 Aug; 45(14):3832-9. PubMed ID: 18614234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties.
    Pommié C; Levadoux S; Sabatier R; Lefranc G; Lefranc MP
    J Mol Recognit; 2004; 17(1):17-32. PubMed ID: 14872534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of the buried glutamine or glutamate residue in position 6 on the structure of immunoglobulin variable domains.
    Honegger A; Plückthun A
    J Mol Biol; 2001 Jun; 309(3):687-99. PubMed ID: 11397089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles for the analysis of immunoglobulin sequences: comparison of V gene subgroups.
    Harris L; Bajorath J
    Protein Sci; 1995 Feb; 4(2):306-10. PubMed ID: 7757019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction.
    Oliva B; Bates PA; Querol E; Avilés FX; Sternberg MJ
    J Mol Biol; 1998 Jun; 279(5):1193-210. PubMed ID: 9642095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conserved amino acid networks involved in antibody variable domain interactions.
    Wang N; Smith WF; Miller BR; Aivazian D; Lugovskoy AA; Reff ME; Glaser SM; Croner LJ; Demarest SJ
    Proteins; 2009 Jul; 76(1):99-114. PubMed ID: 19089973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of covariation in an SH3 domain sequence alignment: applications in tertiary contact prediction and the design of compensating hydrophobic core substitutions.
    Larson SM; Di Nardo AA; Davidson AR
    J Mol Biol; 2000 Oct; 303(3):433-46. PubMed ID: 11031119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
    Narayanan A; Sellers BD; Jacobson MP
    J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains.
    Honegger A; Malebranche AD; Röthlisberger D; Plückthun A
    Protein Eng Des Sel; 2009 Mar; 22(3):121-34. PubMed ID: 19136675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-assisted modeling of antibody variable domains.
    Ramos OH
    Methods Mol Biol; 2012; 907():39-55. PubMed ID: 22907344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold.
    Jespers L; Schon O; James LC; Veprintsev D; Winter G
    J Mol Biol; 2004 Apr; 337(4):893-903. PubMed ID: 15033359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SnapDRAGON: a method to delineate protein structural domains from sequence data.
    George RA; Heringa J
    J Mol Biol; 2002 Feb; 316(3):839-51. PubMed ID: 11866536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains.
    Jung S; Spinelli S; Schimmele B; Honegger A; Pugliese L; Cambillau C; Plückthun A
    J Mol Biol; 2001 Jun; 309(3):701-16. PubMed ID: 11397090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell receptor/peptide/MHC molecular characterization and standardized pMHC contact sites in IMGT/3Dstructure-DB.
    Kaas Q; Lefranc MP
    In Silico Biol; 2005; 5(5-6):505-28. PubMed ID: 16268793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of an isolated V(alpha) domain of the 2C T-cell receptor.
    Rudolph MG; Huang M; Teyton L; Wilson IA
    J Mol Biol; 2001 Nov; 314(1):1-8. PubMed ID: 11724527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of a non-camelized human M12-V(H) domain at 1.5A resolution.
    Gaur RK
    J Struct Biol; 2005 Oct; 152(1):84-9. PubMed ID: 16183303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of CH1 domains in different classes of murine antibodies.
    Sheriff S; Jeffrey PD; Bajorath J
    J Mol Biol; 1996 Nov; 263(3):385-9. PubMed ID: 8918594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMGT unique numbering for immunoglobulin and T cell receptor constant domains and Ig superfamily C-like domains.
    Lefranc MP; Pommié C; Kaas Q; Duprat E; Bosc N; Guiraudou D; Jean C; Ruiz M; Da Piédade I; Rouard M; Foulquier E; Thouvenin V; Lefranc G
    Dev Comp Immunol; 2005; 29(3):185-203. PubMed ID: 15572068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.